Search Results for "verapamil"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for verapamil. Results 1 to 10 of 59 total matches.

Nisoldipine-A New Calcium-Channel Blocker for Hypertension

   
The Medical Letter on Drugs and Therapeutics • Feb 16, 1996  (Issue 968)
for treatment of hypertension in the USA, except for verapamil and diltiazem, are dihydropyridines. Verapamil ...
Nisoldipine (Sular -Zeneca), a dihydropyridine calcium-channel blocker structurally similar to nifedipine, has been approved for marketing by the US Food and Drug Administration. It is available in an oral extended-release formulation for treatment of hypertension.
Med Lett Drugs Ther. 1996 Feb 16;38(968):13-4 |  Show IntroductionHide Introduction

Amlodipine - A New Calcium-Channel Blocker

   
The Medical Letter on Drugs and Therapeutics • Oct 30, 1992  (Issue 882)
Nifedipine − Procardia XL (Pfizer) 30 mg once daily 32.85 Verapamil − average generic price (range: $10.13 ...
Amlodipine (am loe' di peen) besylate (Norvasc - Pfizer), a dihydropyridine calcium-channel blocker, has been approved by the US Food and Drug Administration for once-daily oral treatment of hypertension, chronic stable angina, and vasospastic (Prinzmetal's) angina.
Med Lett Drugs Ther. 1992 Oct 30;34(882):99-100 |  Show IntroductionHide Introduction

Drugs for Stable Angina Pectoris

   
The Medical Letter on Drugs and Therapeutics • Dec 09, 1994  (Issue 937)
Cardizem CD 120 to 480 mg once daily 31.32 Verapamil 80 to 120 mg tid or qid average generic price 20.73 ...
Many nitrates, beta-blockers, and calcium-channel blockers have now been approved by the US Food and Drug Administration for treatment of stable angina pectoris. The table beginning on page 112 lists the individual drugs, their dosage, and their cost.
Med Lett Drugs Ther. 1994 Dec 9;36(937):111-4 |  Show IntroductionHide Introduction

Adenosine

   
The Medical Letter on Drugs and Therapeutics • Jun 29, 1990  (Issue 821)
. It was at least as effective as verapamil (Isoptin; and others) in terminating these tachycardias, and some ...
Adenosine (Adenocard - Fujisawa), an endogenous purine nucleoside, was recently approved by the US Food and Drug Administration for intravenous treatment of paroxysmal supraventricular tachycardia, including Wolff-Parkinson-White (WPW) syndrome. Adenosine is not approved for and has not been effective in treating atrial flutter, atrial fibrillation, or ventricular tachycardias.
Med Lett Drugs Ther. 1990 Jun 29;32(821):63 |  Show IntroductionHide Introduction

Isradipine For Hypertension

   
The Medical Letter on Drugs and Therapeutics • May 31, 1991  (Issue 845)
) 20 mg tid 31.96 Nifedipine − Procardia XL (Pfizer) 30 mg once 31.59 Verapamil − average generic ...
Isradipine (DynaCirc - Sandoz), a dihydropyridine calcium-channel blocker chemically related to nicardipine (Cardene) and nifedipine (Procardia, and others), was recently approved by the US Food and Drug Administration for oral treatment of hypertension.
Med Lett Drugs Ther. 1991 May 31;33(845):51-2 |  Show IntroductionHide Introduction

Nicardipine - A New Calcium-Entry Blocker

   
The Medical Letter on Drugs and Therapeutics • May 05, 1989  (Issue 791)
mg bid, verapamil (Calan; and others) 160 mg bid, or propranolol (Inderal; and others) 80 mg tid ...
Nicardipine (Cardene - Syntex), a dihydropyridine calcium-entry blocker structurally related to nifedipine (Procardia; Adalat), was recently approved by the US Food and Drug Administration for oral treatment of angina and hypertension. Advertisements for the drug claim that nicardipine is more vasoselective; than other calcium-channel blockers and does not depress myocardial contractility.
Med Lett Drugs Ther. 1989 May 5;31(791):41-2 |  Show IntroductionHide Introduction

Drugs for Cardiac Arrhythmias

   
Treatment Guidelines from The Medical Letter • Jun 01, 2007  (Issue 58)
using adenosine; other options are intravenous (IV) verapamil, diltiazem or a beta-blocker ...
The drugs of choice for treatment of common cardiac arrhythmias are listed in Tables 1 and 2. Some drugs are recommended for indications that have not been approved by the FDA.
Treat Guidel Med Lett. 2007 Jun;5(58):51-8 |  Show IntroductionHide Introduction

Felodipine - Calcium-Channel Blocker For Hypertension

   
The Medical Letter on Drugs and Therapeutics • Dec 13, 1991  (Issue 859)
− Procardia XL (Pfizer) 30 mg once daily 31.59 Verapamil − average generic price (range: $6.07 to $22.59) 80 ...
Felodipine (Plendil - Merck), an extended-release preparation of a dihydropyridine calcium-channel blocker was recently marketed in the USA for oral treatment of hypertension. An immediate-release formulation is available in some other countries.
Med Lett Drugs Ther. 1991 Dec 13;33(859):115-6 |  Show IntroductionHide Introduction

Safety of Calcium-Channel Blockers

   
The Medical Letter on Drugs and Therapeutics • Feb 14, 1997  (Issue 994)
arrhythmias Verapamil − immediate-release − Isoptin; Calan ✔ Long-acting Bepridil − Vascor ✔ Diltiazem ...
Reports of increased mortality associated with calcium-channel blockers have caused concerns among patients taking these drugs and their physicians.
Med Lett Drugs Ther. 1997 Feb 14;39(994):13-4 |  Show IntroductionHide Introduction

Mibefradil--A New Calcium-Channel Blocker

   
The Medical Letter on Drugs and Therapeutics • Nov 07, 1997  (Issue 1013)
coronary and peripheral blood vessels. Verapamil and diltiazem are more likely than dihydropyridines ...
Mibefradil dihydrochloride (Posicor - Roche), a chemically distinct nondihydropyridine calcium-channel blocker, has been approved by the US Food and Drug Administration (FDA) and is being heavily promoted as the first T-type calcium-channel blocker for treatment of hypertension and chronic stable angina.
Med Lett Drugs Ther. 1997 Nov 7;39(1013):103-5 |  Show IntroductionHide Introduction